Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

EFFECTS OF VARIATIONS IN STIMULUS INTENSITY ON MAXIMAL ELECTROSHOCK SEIZURE PATTERN, RECOVERY TIME, AND ANTICONVULSANT POTENCY OF PHENOBARBITAL IN MICE

David H. Tedeschi, Ewart A. Swinyard and Louis S. Goodman
Journal of Pharmacology and Experimental Therapeutics January 1956, 116 (1) 107-113;
David H. Tedeschi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ewart A. Swinyard
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Louis S. Goodman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Maximal electroshock seizures were induced in adult male albino mice with current intensities of 12.5, 25, 50, 200, and 400 mA (60-cycle a.c., 0.2-second duration, corneal electrodes), and the following variables measured: seizure pattern and duration, time for 50 per cent of animals to recover the ability to exhibit a second tonic-clonic seizure after an initial seizure (RT50), and anticonvulsant potency of phenobarbital. The results were as follows:

1. The mean duration of hindleg tonic flexion increased as the stimulus intensity was increased. The mean duration of hindleg tonic extension was significantly longer only in seizures evoked by a stimulus intensity of 400 mA. The flexion/extension ratio progressively decreased as the stimulus intensity was increased. The mean duration of terminal clonus did not vary with the intensity of the stimulus. The mean total duration of seizures elicited with 12.5 and 400 mA of current was significantly longer than those evoked with the other stimulus intensities.

2 A statistically significant increase in RT50 was observed as the intensity of the stimulus employed to evoke the initial seizure was increased. There was a direct linear relation between log RT50 and log stimulus intensity.

3. Variations in current strength from 50 to 800 per cent of the standard stimulus failed to effect a significant change in phenobarbital anticonvulsant potency.

It is concluded that increased stimulus intensity increases seizure severity, and that hindleg tonic-flexion duration and recovery time are more sensitive measures of seizure severity than is phenobarbital anticonvulsant potency; the latter, as determined by the conventional test which is based on the prevention of the hindleg tonic-extensor component of the maximal electroshock seizure, is relatively independent of stimulus intensity.

Footnotes

    • Received August 6, 1955.

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 116, Issue 1
1 Jan 1956
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
EFFECTS OF VARIATIONS IN STIMULUS INTENSITY ON MAXIMAL ELECTROSHOCK SEIZURE PATTERN, RECOVERY TIME, AND ANTICONVULSANT POTENCY OF PHENOBARBITAL IN MICE
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

EFFECTS OF VARIATIONS IN STIMULUS INTENSITY ON MAXIMAL ELECTROSHOCK SEIZURE PATTERN, RECOVERY TIME, AND ANTICONVULSANT POTENCY OF PHENOBARBITAL IN MICE

David H. Tedeschi, Ewart A. Swinyard and Louis S. Goodman
Journal of Pharmacology and Experimental Therapeutics January 1, 1956, 116 (1) 107-113;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

EFFECTS OF VARIATIONS IN STIMULUS INTENSITY ON MAXIMAL ELECTROSHOCK SEIZURE PATTERN, RECOVERY TIME, AND ANTICONVULSANT POTENCY OF PHENOBARBITAL IN MICE

David H. Tedeschi, Ewart A. Swinyard and Louis S. Goodman
Journal of Pharmacology and Experimental Therapeutics January 1, 1956, 116 (1) 107-113;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • PST3093 Stimulates SERCA2a and Improves Cardiac Function
  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Is Hydroxylamine-Induced Cytotoxicity a Valid Marker for Hypersensitivity Reactions to Sulfamethoxazole in Human Immunodeficiency Virus-Infected Individuals?
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics